BCRX CIK: 882796

BioCryst Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−142
FY22:
−162
FY23:
−95.1
FY24:
−52.0
FY25:
347
Change from FY21 to FY25
millions USD
FY21:
15.8
FY22:
−128
FY23:
−131
FY24:
52.6
FY25:
−13.7
Change from FY21 to FY25
millions USD
FY21:
360
FY22:
88.0
FY23:
32.5
FY24:
−5.76
FY25:
−350
millions USD
FY21:
233
FY22:
−201
FY23:
−194
FY24:
−6.12
FY25:
−15.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−145
FY22:
−163
FY23:
−97.3
FY24:
−53.1
FY25:
345

All amounts in millions USD Data source:SEC EDGAR